Hsu C P, Wu C C, Chen C Y, Hsu N Y, Wang P Y
Department of Surgery, Taichung Veterans General Hospital, Taiwan, Republic of China.
J Thorac Cardiovasc Surg. 1997 Oct;114(4):544-51. doi: 10.1016/S0022-5223(97)70042-4.
We evaluated the pattern of nodal metastasis and its prognosis after radical lymphadenectomy in adenocarcinoma of the gastric cardia.
We conducted a retrospective cohort study of 70 patients (52 men and 18 women; mean age 63.6 years) with adenocarcinomas of the gastric cardia who underwent extended gastrectomy (65 total gastrectomies and 5 proximal gastrectomies) and radical lymphadenectomy (D2 to D4) at Taichung Veterans General Hospital between 1989 and 1995.
Twenty-four complications developed in 22 (31.4%) patients, and seven (10.0%) hospital deaths occurred. An overall 5-year cumulative survival of 37.6% was obtained. Lymph node metastases were identified in 53 (75.7%) patients. Nodal involvement was closely related to the depth of tumor invasion (p = 0.005). When the gastric wall invasion was limited to the subserosal layer (T1 and T2, n = 15), no patient had N4 group nodal metastasis. Once the serosal layer had been involved (beyond T3), N4 group nodal metastasis was frequently seen (30.9%, 17 of 55 patients). A multivariable analysis revealed that the level of nodal involvement, the depth of tumor invasion, and the presence of complications were independent prognostic factors. Cumulative 5-year survivals of curability A (n = 12), B (n = 19), and C (n = 32) resections were 100%, 21.2%, and 27.5%, respectively (p = 0.0001). The long-term survival of the patients after resection was also closely related to their pTNM stages (p = 0.0004).
We conclude that gastrectomy accompanied by radical lymphadenectomy provides a reasonable long-term survival expectancy that is closely related to the stage of the disease and the curability of resection.
我们评估了贲门腺癌根治性淋巴结清扫术后的淋巴结转移模式及其预后。
我们对1989年至1995年间在台中荣民总医院接受扩大胃切除术(65例全胃切除术和5例近端胃切除术)及根治性淋巴结清扫术(D2至D4)的70例贲门腺癌患者(52例男性和18例女性;平均年龄63.6岁)进行了一项回顾性队列研究。
22例(31.4%)患者发生了24例并发症,7例(10.0%)患者死亡。总体5年累积生存率为37.6%。53例(75.7%)患者发现有淋巴结转移。淋巴结受累与肿瘤浸润深度密切相关(p = 0.005)。当胃壁浸润局限于浆膜下层(T1和T2,n = 15)时,无患者发生N4组淋巴结转移。一旦浆膜层受累(超过T3),N4组淋巴结转移常见(30.9%,55例患者中的17例)。多变量分析显示,淋巴结受累程度、肿瘤浸润深度和并发症的存在是独立的预后因素。A(n = 12)、B(n = 19)和C(n = 32)级切除的累积5年生存率分别为100%、21.2%和27.5%(p = 0.0001)。切除术后患者的长期生存也与其pTNM分期密切相关(p = 0.0004)。
我们得出结论,胃切除术联合根治性淋巴结清扫术可提供合理的长期生存预期,这与疾病分期和切除的可治愈性密切相关。